Export control regimes for sensitive biotech technologies

Introduction

Export control regimes for sensitive biotechnology technologies are legal and regulatory systems designed to monitor and restrict the international transfer of biological materials, equipment, scientific information and technological capabilities that may create risks to public health, national security or international peace.

Sensitive biotechnology technologies include genetic engineering systems, gene-editing tools, pathogen research materials, synthetic biology platforms, advanced vaccine manufacturing technologies, biological production equipment and specialised laboratory instruments.

These technologies have significant applications in medicine, agriculture, pharmaceuticals and scientific research. However, certain technologies may have dual-use potential, meaning they can be used for peaceful scientific purposes as well as prohibited biological-weapons activities. Export control regimes therefore seek to balance scientific development with national security and international obligations.

Legal framework governing export controls in India

1. Foreign Trade (Development and Regulation) Act, 1992

The Foreign Trade (Development and Regulation) Act provides the primary statutory framework for regulating exports from India. Section 3 empowers the Central Government to prohibit, restrict or regulate exports through official orders and notifications.

The Directorate General of Foreign Trade (DGFT) administers export policy and controls specified sensitive goods and technologies through the SCOMET (Special Chemicals, Organisms, Materials, Equipment and Technologies) framework.

SCOMET includes controlled categories covering certain biological agents, toxins, related equipment and technologies. Exporters must examine the relevant technical classification and obtain authorisation where required. Not every biotechnology product or scientific instrument is automatically subject to export licensing.

2. Weapons of Mass Destruction and their Delivery Systems (Prohibition of Unlawful Activities) Act, 2005

This Act provides an important legal framework for preventing the proliferation of weapons of mass destruction. It prohibits unlawful activities connected with biological, chemical and nuclear weapons and their delivery systems.

The legislation is particularly relevant to sensitive biotechnology because certain biological agents, toxins and related technologies may have applications that are inconsistent with peaceful scientific purposes.

3. Environment (Protection) Act, 1986

The Environment (Protection) Act and the Rules for the Manufacture, Use, Import, Export and Storage of Hazardous Microorganisms, Genetically Engineered Organisms or Cells, 1989 regulate specified activities involving genetically engineered organisms and hazardous microorganisms.

The regulatory framework includes Institutional Biosafety Committees, the Review Committee on Genetic Manipulation and the Genetic Engineering Appraisal Committee. Their respective responsibilities depend on the activity and applicable regulatory requirements.

4. Customs Act, 1962

The Customs Act provides enforcement mechanisms for regulating goods crossing India's borders. Exporters must comply with applicable declarations, licensing conditions and restrictions. Customs authorities can take action against prohibited or improperly declared exports under the relevant statutory provisions.

Major international export control regimes

1. Biological Weapons Convention, 1972

The Biological Weapons Convention prohibits the development, production, acquisition and stockpiling of biological agents and toxins for hostile purposes or in quantities unjustified by peaceful purposes.

Article I establishes the principal prohibition, while Article III addresses transfers of biological agents, toxins, weapons and associated equipment to recipients for prohibited purposes.

The Convention is particularly important for regulating sensitive biotechnology because it establishes international obligations against biological-weapons proliferation.

2. Australia Group

The Australia Group is an informal international export-control arrangement established to prevent the proliferation of chemical and biological weapons.

Its participants coordinate national controls over specified biological agents, toxins, chemicals, equipment and related technologies. It is not an international treaty, but its control lists influence national export-control systems.

3. Wassenaar Arrangement

The Wassenaar Arrangement promotes transparency and responsibility in transfers of conventional arms and dual-use goods and technologies.

Certain advanced manufacturing equipment, specialised laboratory equipment, software and technical information may fall within its control lists. Whether a particular biotechnology product is controlled depends on its technical characteristics and the relevant entry.

4. United Nations Security Council Resolution 1540 (2004)

Resolution 1540 requires states to establish appropriate controls to prevent non-state actors from acquiring weapons of mass destruction and related materials.

It calls for effective export, transit, trans-shipment and border controls concerning sensitive biological materials and related technologies.

Major legal challenges in biotechnology export control

1. Dual-use research regulation

One of the most difficult challenges is distinguishing legitimate scientific research from activities that may create biological security risks. A technology developed for vaccine production or disease research may also have sensitive applications.

Export authorities must assess the product's technical characteristics, intended purpose, end user and destination.

2. Regulation of intangible technology transfers

Sensitive biotechnology knowledge may be transferred through digital documents, technical assistance, software, research collaboration and remote access.

Traditional export-control systems were primarily designed around physical goods. Modern regulatory systems must also address controlled technical information and intangible transfers where national laws provide for such controls.

3. International regulatory differences

Different countries maintain different controlled-item lists, licensing procedures and biosafety standards. These differences create compliance difficulties for biotechnology companies operating internationally.

4. Scientific freedom and national security

Excessive export restrictions may interfere with legitimate scientific collaboration, academic research and access to medical technologies. Governments must therefore establish proportionate controls that address genuine security risks without unnecessarily restricting peaceful research.

Important judicial and international decisions

1. United States v. Roth (2011)

This case involved unlawful export-related conduct concerning sensitive military technology. Although it was not a biotechnology dispute, it demonstrates the legal significance of export-control compliance and the consequences of unauthorised transfers of controlled technology.

2. United States v. Zhen Zhou Wu (2014)

This prosecution concerned the unlawful export of sensitive technology from the United States. It illustrates the importance of accurate classification, licensing and compliance with restrictions governing international technology transfers. Its relevance to biotechnology is indirect.

3. Diamond v. Chakrabarty (1980)

The United States Supreme Court recognised the patentability of a genetically engineered microorganism under US patent law. Although the case concerned intellectual property rather than export restrictions, it demonstrates how biotechnology innovations can acquire significant commercial and technological value, making appropriate regulatory oversight important.

4. Vellore Citizens' Welfare Forum v. Union of India (1996)

The Supreme Court of India recognised the precautionary principle as part of Indian environmental law. This principle is relevant by analogy when evaluating biotechnology activities that may create serious or irreversible environmental risks.

5. A.P. Pollution Control Board v. Prof. M.V. Nayudu (1999)

The Supreme Court highlighted the importance of scientific expertise in environmental decision-making, particularly where complex scientific uncertainty exists. The judgment is relevant to biotechnology regulation because export-control authorities may require expert assessment of biological risks and technological capabilities.

Compliance requirements for biotechnology exporters

Organisations dealing with sensitive biotechnology should establish a structured compliance programme.

Important measures include:

Classifying biological materials, equipment and technologies under applicable export-control lists.

Obtaining DGFT or other required export authorisations.

Screening foreign buyers, research institutions and end users.

Verifying the intended purpose and final destination of controlled materials.

Maintaining records of licences, shipments and technical transfers.

Reviewing applicable biosafety, customs and destination-country requirements.

Conducting periodic internal compliance audits and employee training.

Conclusion

Export control regimes for sensitive biotechnology technologies play an important role in preventing biological-weapons proliferation while protecting legitimate scientific and commercial activities. In India, the Foreign Trade Act, WMD Act, Environment (Protection) Act and Customs Act establish important domestic regulatory foundations. International frameworks such as the Biological Weapons Convention, Australia Group, Wassenaar Arrangement and UN Security Council Resolution 1540 strengthen international cooperation. Although direct judicial decisions specifically addressing biotechnology export-control regimes remain limited, export-control and environmental jurisprudence provide useful legal principles. Effective regulation requires accurate classification, risk assessment, licensing, end-user verification and international coordination.